Ibrahim M. Abdou

476 total citations
30 papers, 375 citations indexed

About

Ibrahim M. Abdou is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Ibrahim M. Abdou has authored 30 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 14 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ibrahim M. Abdou's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Ibrahim M. Abdou is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (8 papers) and Synthesis and Characterization of Heterocyclic Compounds (6 papers). Ibrahim M. Abdou collaborates with scholars based in United Arab Emirates, United States and Egypt. Ibrahim M. Abdou's co-authors include Shaikha S. AlNeyadi, Ayman Saleh, Alaa A. Salem, Hussein F. Zohdi, Lucjan Strękowski, Mohammad A. Ghattas, Noor Atatreh, Adel M. Attia, Yuguang Mu and Ahmed H. Moustafa and has published in prestigious journals such as Tetrahedron, Molecules and The Journal of Physical Chemistry A.

In The Last Decade

Ibrahim M. Abdou

28 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim M. Abdou United Arab Emirates 12 294 93 27 24 23 30 375
Shrinivas D. Joshi India 13 407 1.4× 101 1.1× 56 2.1× 21 0.9× 20 0.9× 38 513
Pankaj B. Miniyar India 10 260 0.9× 112 1.2× 31 1.1× 21 0.9× 13 0.6× 19 387
Raviraj S. Pattanashettar India 4 303 1.0× 110 1.2× 29 1.1× 14 0.6× 19 0.8× 7 413
Abdeslem Bouzina Algeria 13 346 1.2× 133 1.4× 21 0.8× 16 0.7× 28 1.2× 42 430
Nasser A. Hassan Egypt 15 477 1.6× 140 1.5× 49 1.8× 36 1.5× 9 0.4× 48 577
Reham F. Barghash Egypt 14 350 1.2× 101 1.1× 32 1.2× 19 0.8× 13 0.6× 36 472
Atukuri Dorababu India 14 428 1.5× 128 1.4× 54 2.0× 22 0.9× 27 1.2× 36 545
M. A. EL‐GENDY Egypt 10 325 1.1× 109 1.2× 33 1.2× 15 0.6× 13 0.6× 20 445
T. Arulmoli India 9 379 1.3× 100 1.1× 28 1.0× 19 0.8× 12 0.5× 13 466
Wagnat W. Wardakhan Egypt 12 417 1.4× 90 1.0× 36 1.3× 7 0.3× 23 1.0× 40 480

Countries citing papers authored by Ibrahim M. Abdou

Since Specialization
Citations

This map shows the geographic impact of Ibrahim M. Abdou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim M. Abdou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim M. Abdou more than expected).

Fields of papers citing papers by Ibrahim M. Abdou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim M. Abdou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim M. Abdou. The network helps show where Ibrahim M. Abdou may publish in the future.

Co-authorship network of co-authors of Ibrahim M. Abdou

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim M. Abdou. A scholar is included among the top collaborators of Ibrahim M. Abdou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim M. Abdou. Ibrahim M. Abdou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
AlNeyadi, Shaikha S., Abdu Adem, Mohammad A. Ghattas, et al.. (2021). Activation of the GLP-1 receptor by chloropyrimidine derivatives. Results in Chemistry. 3. 100222–100222. 1 indexed citations
3.
AlNeyadi, Shaikha S., et al.. (2020). Anticancer activity of novel Schiff bases and azo dyes derived from 3-amino-4-hydroxy-2H-pyrano[3,2-c]quinoline-2,5(6H)-dione. Heterocyclic Communications. 26(1). 192–205. 31 indexed citations
4.
Abdou, Ibrahim M., et al.. (2020). Anti-Cancer Activity and Molecular Docking of Some Pyrano[3,2‑c]quinoline Analogues. 10(1). 1–14. 11 indexed citations
5.
AlNeyadi, Shaikha S., et al.. (2017). Synthesis and in vitro biological evaluation of new pyrimidines as glucagon-like peptide-1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 27(22). 5071–5075. 2 indexed citations
6.
AlNeyadi, Shaikha S., et al.. (2017). Synthesis and antimicrobial activity of 4-trifluoromethylpyridine nucleosides. Heterocyclic Communications. 23(3). 197–203. 6 indexed citations
7.
AlNeyadi, Shaikha S., Alaa A. Salem, Mohammad A. Ghattas, Noor Atatreh, & Ibrahim M. Abdou. (2017). Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: In vitro , spectroscopic, and docking studies. European Journal of Medicinal Chemistry. 136. 270–282. 43 indexed citations
8.
Saleh, Ayman, Mohammad Azhar Aziz, Ibrahim M. Abdou, et al.. (2016). Cytotoxic activity of the novel heterocyclic compound G-11 is primarily mediated through intrinsic apoptotic pathway. APOPTOSIS. 21(7). 873–886. 4 indexed citations
9.
Abdou, Ibrahim M. & Shaikha S. AlNeyadi. (2015). Synthesis of quinazolines and quinazolinones via palladium-mediated approach. Heterocyclic Communications. 21(3). 115–132. 32 indexed citations
10.
AlNeyadi, Shaikha S., Ihsan Shehadi, & Ibrahim M. Abdou. (2015). Synthesis and anti-proliferative activity of pyridine O -galactosides and 4-fluorobenzoyl analogues. Heterocyclic Communications. 21(5). 285–290. 3 indexed citations
11.
AlNeyadi, Shaikha S., et al.. (2015). Synthesis and Antimicrobial Studies of New Trifluoromethylpyrimidine Analogues. Journal of Pharmacy and Pharmacology. 3(1). 1 indexed citations
12.
Salem, Alaa A., et al.. (2014). Interaction of human telomeric G-quadruplex DNA with thymoquinone: A possible mechanism for thymoquinone anticancer effect. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(2). 329–342. 24 indexed citations
13.
Abdou, Ibrahim M., et al.. (2014). Substituted pyridine derivatives useful in the treatment of cancer, US Patent 2014/0128350 A1. 1 indexed citations
14.
Abdou, Ibrahim M., et al.. (2012). Fast and efficient microwave synthetic methods for some new 2(1 H )-pyridone arabinosides. Heterocyclic Communications. 18(3). 135–141. 2 indexed citations
15.
Salem, Alaa A., et al.. (2012). Application of Quantitative Nuclear Magnetic Resonance Spectroscopy for the Determination of Amantadine and Acyclovir in Plasma and Pharmaceutical Samples. Journal of AOAC International. 95(6). 1644–1651. 4 indexed citations
16.
AlNeyadi, Shaikha S., Ahmed H. Hassan, & Ibrahim M. Abdou. (2011). Microwave-Assisted Synthesis of 2(1H)-Pyridones and Their Glucosides as Cell Proliferation Inhibitors. Nucleosides Nucleotides & Nucleic Acids. 30(2). 120–134. 13 indexed citations
17.
Abdou, Ibrahim M., Ayman Saleh, & Hussein F. Zohdi. (2004). Synthesis and Antitumor Activity of 5-Trifluoromethyl-2,4- dihydropyrazol-3-one Nucleosides. Molecules. 9(3). 109–116. 70 indexed citations
18.
Abdou, Ibrahim M., Adel M. Attia, & Lucjan Strękowski. (2002). Glucopyranosides Derived From 6-Aryl-5-Cyano-2-(Methylthio)Pyrimidin-4(3H)Ones. Nucleosides Nucleotides & Nucleic Acids. 21(1). 15–21. 11 indexed citations
19.
Abdou, Ibrahim M. & Lucjan Strękowski. (1997). SYNTHESIS OF 1-(ß-D-GLUCOPYRANOSYL) PYRIMIDIN-2(1H)-ONES FROM 2-CHLOROPYRIMIDINES. Heterocyclic Communications. 3(4). 295–300. 4 indexed citations
20.
Mokrosz, Maria J., Beata Duszyńska, Aleksandra Kłodzińska, et al.. (1997). 4-(3-furyl)-2-(4-methylpiperazino)pyrimidines: Potent 5-HT2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(13). 1635–1638. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shrinivas D. Joshi Breakdown of academic impact, for papers by Pankaj B. Miniyar Breakdown of academic impact, for papers by Raviraj S. Pattanashettar Breakdown of academic impact, for papers by Abdeslem Bouzina Breakdown of academic impact, for papers by Nasser A. Hassan Breakdown of academic impact, for papers by Reham F. Barghash Breakdown of academic impact, for papers by Atukuri Dorababu Breakdown of academic impact, for papers by M. A. EL‐GENDY Breakdown of academic impact, for papers by T. Arulmoli Breakdown of academic impact, for papers by Wagnat W. Wardakhan
Rankless by CCL
2026